Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Triastek Partners with Johnson & Johnson to Develop Novel Oral Medicines Using 3D Printing Pharmaceutical Technology – JJDC Makes Strategic Equity Investment
CompanyDeals

Triastek Partners with Johnson & Johnson to Develop Novel Oral Medicines Using 3D Printing Pharmaceutical Technology – JJDC Makes Strategic Equity Investment

Triastek (Nanjing) Pharmaceutical Technology Co., Ltd. ("Triastek") announced that it has entered into a Collaboration and License Agreement with Johnson & Johnson (J&J, NYSE: JNJ), combining J&J's expertise in drug…

Viatris to Acquire Pacira BioSciences for USD 1.65 Billion – Expanding Non‑Opioid Pain Portfolio with EXPAREL and ZILRETTA

Viatris to Acquire Pacira BioSciences for USD 1.65 Billion – Expanding Non‑Opioid Pain Portfolio with EXPAREL and ZILRETTA

FDA Approves Genentech's Tecentriq for Adjuvant Treatment of dMMR Colon Cancer – Landmark ATOMIC Trial Shows 50% Risk Reduction

FDA Approves Genentech’s Tecentriq for Adjuvant Treatment of dMMR Colon Cancer – Landmark ATOMIC Trial Shows 50% Risk Reduction

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyMedical Device

Blue Sail Medical’s Fastroad Catheter Earns NMPA Marketing Approval

CompanyDrug

Astellas Pharma’s Xtandi Secures Third Market Approval in China for Prostate Cancer Treatment

CompanyDrug

China’s Jiangsu Hengrui First to Market Generic Exparel in the US with FDA ANDA Approval

CompanyDrug

MabPharm’s Biosimilar Infliximab CMAB807 Receives Market Approval in Peru

CompanyDrug

Eisai and Biogen Launch Alzheimer’s Drug Leqembi in China Following Market Approval

CompanyDrug

Jiangsu Hengrui’s Henagliflozin Gains Expanded Indication for Type 2 Diabetes Treatment in China

CompanyDrug

BeiGene’s Tislelizumab Approved by China’s NMPA for First-Line Extensive Stage Small Cell Lung Cancer

CompanyDrug

CSPC Pharmaceutical’s Enronsubaimab Gets NMPA Nod for Recurrent Cervical Cancer

Show More